- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
PMCPA case AUTH/2491/3/12 (Member of the public v Roche) about conduct of a clinical trial. The matter was ruled outside the scope…
A Toujeo promotional leavepiece highlighted favourable 0–12 week hypoglycaemia results vs degludec with prominent graphics, while 24‑week comparable outcomes were downplayed. PMCPA…
PMCPA case AUTH/2894/11/16 (Director v Mitsubishi Tanabe) concerning clinical trial disclosure for BindRen. The case outcome was no breach and it was…
Anonymous employee complaint about Leo’s dermatology MSLs. Panel found some MSL speaker-meeting activity was promotional, so MSLs should have taken an appropriate…
Complaint alleged Pradaxa.co.uk encouraged the public to seek more info about a POM. Panel found the public-facing section was factual reference material,…
A UK health professional alleged Symbicort COPD formulary material omitted a newer SPC warning. PMCPA found the warning related to asthma, not…
After inter-company dialogue, Ipsen’s Dysport messaging implying superior duration of effect was found misleading and not supportive of rational use. Appeal Board…
Anonymous group alleged a third-party email showed commercial bias in Novartis-sponsored heart failure therapy reviews. Panel and Appeal Board had concerns about…
A UK health professional alleged GSK’s public Anoro Ellipta webpage promoted a POM and encouraged requests for treatment, and questioned certification/expiry. The…
A Janssen UK employee reposted/commented on a US exec’s LinkedIn update about a Covid-19 vaccine candidate entering Phase 3. Panel ruled pre-authorisation…
Ex-employee alleged Apo-Go advisory boards were promotional. Panel found high standards breach (9.1). On appeal, poor documentation, SOP deviations and missing minutes…
A senior Pfizer UK employee posted a proud LinkedIn message linking to a BBC article with an unqualified “safe” headline about the…
An internal salesforce email mixing patient booklet availability with digital campaign screenshots wasn’t itself improper, but it was treated as rep briefing/instructions…
Novartis’ corporate webpage listed pipeline products with indications and trial details. PMCPA ruled it promoted two licensed POMs to the public and…
Anonymous UK health professional alleged a Vifor-sponsored PIVOTAL sub-analysis symposium promoted off-licence Venofer use. Panel found PIVOTAL dosing aligned with clinically accepted…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.